Latest Ratings for OB Date Firm Action From To Mar 2022 JMP Securities Maintains Market Outperform Jan 2022 Jefferies Upgrades Hold Buy Aug 2021 Barclays Initiates Coverage On Overweight View More Analyst Ratings for OB View the Latest Analyst Ratings read more
Latest Ratings for PCRX Date Firm Action From To Feb 2022 Wedbush Maintains Outperform Feb 2022 HC Wainwright & Co. Maintains Buy Jan 2022 Barclays Maintains Overweight View More Analyst Ratings for PCRX View the Latest Analyst Ratings read more
Amneal Pharmaceuticals’ Q4 sales rose 18% to $730.52M, surpassing estimates, while adjusted EPS missed. The company forecasts up to $3.1B in 2025 revenue. read more
Alibaba Group offers 3,000 internships, over half in AI. Plans to invest $52.2B in AI and cloud computing. Stock down 4.61%. read more
Deepwater’s Gene Munster, shared his views on Nvidia Corporation (NASDAQ: NVDA) recent performance, suggesting it was solid but fell short of extraordinary expectations. However, he remains upbeat on the stock. read more
A Pakistani astronaut will fly to the Chinese space station in the coming years, making them the first foreign national to visit the station. read more
Bitcoin (CRYPTO: BTC) continues to tumble, falling as low as $78,433 in early Friday morning hours amid a record streak of spot Bitcoin ETF outflows. read more
While some analysts say Nvidia’s fall could be because of the outlook on “gross margins,” others believe that these concerns are “misplaced”. read more